Skip to content

Bioequivalence clinical trial of two formulations of empagliflozin/metformin

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-527325-35-00
Enrollment
30
Registered
2026-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Sponsors

Laboratorios Normon S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 27, 2026